EVOK News Alert Evoke Pharma Inc (EVOK) 5.41 02/13/2015 23:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Evoke Pharma Inc (EVOK) 5.41 $EVOK

Nasdaq stocks posting largest percentage decreases
AP - Tue Feb 03, 5:44PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
HTBX: 5.83 (+0.22), ADXS: 7.18 (+0.06), OPHT: 51.11 (+0.12), LMNX: 15.45 (+0.02), ENTA: 33.30 (-0.44), ORPN: 7.17 (+0.04), EVOK: 5.41 (-0.10), RCII: 30.49 (+0.92), SCYX: 9.48 (+0.07), SSYS: 67.16 (-0.34), AKBA: 9.32 (+0.51), VBLT: 14.11 (+0.24)

Evoke Pharma Outlines Progress on Clinical Program
GlobeNewswire - Mon Feb 02, 9:05AM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today provided an update on its clinical program for EVK-001, its novel metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women.
EVOK: 5.41 (-0.10)

Patient enrollment sub par in Phase 3 study of Evoke's lead product candidate
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 8:27AM CST

EVOK: 5.41 (-0.10)

Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 09, 3:39PM CST
Impax's shares hit a 52-week high with the FDA approval of Parkinson's disease drug, Rytary.
IPXL: 39.51 (+0.69), EVOK: 5.41 (-0.10), MYL: 55.85 (+1.34), TEVA: 56.77 (-0.58)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 11:47AM CST

CY: 14.76 (+0.01), QDEL: 25.18 (+0.35), WLT: 1.09 (+0.05), VNCE: 24.68 (+0.22), ISNS: 2.49 (+0.03), VII: 1.47 (-0.02), NTLS: 5.19 (+0.05), MFRM: 62.22 (-0.12), GSAT: 2.40 (+0.08), MOLG: 2.46 (+0.03), EVOK: 5.41 (-0.10), IDRA: 4.10 (-0.14), SCVL: 24.02 (-0.06), VGGL: 1.77 (-0.08), MIXT: 5.69 (+0.08), ENVI: 1.45 (-0.01), REI: 10.00 (+0.27), TRX: 0.57 (+0.01), DGLY: 11.50 (-0.40), CODE: 35.99 (+0.03)

Evoke clears another hurdle on its path to NDA for metoclopramide nasal spray
Seeking Alpha - at Seeking Alpha - Tue Dec 02, 8:05AM CST

EVOK: 5.41 (-0.10)

Evoke Pharma's EVK-001 Showed No QT Prolongation in Thorough ECG (TQT) Study
GlobeNewswire - Tue Dec 02, 7:30AM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced results from an electrocardiogram (ECG) study that assessed the potential of metoclopramide nasal spray (EVK-001) to increase the cardiac QT and corrected QT (QTc) interval across a range of plasma concentrations. The study was conducted to satisfy a safety requirement by the U.S. Food and Drug Administration (FDA) in support of the submission of a New Drug Application (NDA) for EVK-001, an investigational medication for relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The study met the pre-specified primary endpoint, demonstrating that EVK-001, at therapeutic and supratherapeutic doses, did not prolong the QT/QTc interval in healthy subjects.
EVOK: 5.41 (-0.10)

Evoke Pharma to Present at LD Micro Conference
GlobeNewswire - Tue Nov 25, 7:31AM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an investor presentation on Thursday, December 4, 2014 at 11:30AM PT at the LD Micro Main Event VII Conference. The conference is being held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
EVOK: 5.41 (-0.10)

Dr. Kenneth J. Widder Joins Quidel's Board of Directors
Marketwired - Wed Nov 19, 3:39PM CST
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Kenneth J. Widder, M.D. has agreed to join Quidel's Board of Directors, effective immediately. Quidel's Board has been expanded to eight members.
EVOK: 5.41 (-0.10), QDEL: 25.18 (+0.35)

Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 9.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 8:32AM CST
Supernus Pharmaceuticals, Inc. (SUPN) was a big mover last session, as the company saw its shares nearly 10% on the day.
EVOK: 5.41 (-0.10), AKRX: 47.28 (-0.25), SUPN: 8.80 (+0.22)

Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 13, 8:04PM CST

EVOK: 5.41 (-0.10)

Evoke Pharma beats by $0.15
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 3:10PM CST

EVOK: 5.41 (-0.10)

Evoke Pharma Reports Third Quarter 2014 Results
GlobeNewswire - Thu Nov 13, 3:09PM CST
Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the third quarter ended September 30, 2014.
EVOK: 5.41 (-0.10)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 6

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 5

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 3

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 9

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 12

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 10

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 6

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 13

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 7

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Art Print Paper: Finding the Perfect Match for Masterpieces

Updated Category News Views 13

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Continue Reading

Top 5 Most Recently Viewed Articles

Jonathan Buba Expands Holdings with $4.38M in CRMT Stocks

Updated Category News Views 195

Jonathan Buba's Strategic Investment in America's Car-Mart Recently, a significant insider purchase was reported involving Jonathan Buba, a Board Member at America's Car-Mart (CRMT). This update is drawn from the latest SEC filings. Details of the Transaction On a recent filing, it was highlighted that Buba acquired an impressive 100,000 shares of America's Car-Mart. The...

Continue Reading
Cambodia Microfinance Association: Driving Sustainable Finance

Updated Category News Views 43

Cambodia Microfinance Association Leads Sustainable Finance Initiatives The Cambodia Microfinance Association (CMA) has made remarkable strides in advancing sustainable and inclusive finance through its recent Annual Microfinance Conference. Gathering over three hundred leaders, policymakers, and international partners, the conference centered around the theme...

Continue Reading
Logansport Financial Corp. Shows Remarkable Gain in Earnings

Updated Category News Views 162

Logansport Financial Corp. Earnings Overview Logansport Financial Corp., functioning as the parent company of Logansport Savings Bank, has announced impressive net earnings for the latest quarter. The figures reflect the company's growth and stability, as they reported net earnings of $520,000 or $0.85 per diluted share for the quarter ending on September 30. This marks a...

Continue Reading
Citi and Apollo Launch Massive $25 Billion Financing Initiative

Updated Category News Views 306

Citi and Apollo Global have officially launched a staggering $25 billion private credit program aimed at transforming the financing landscape for North America. This isn't just another run-of-the-mill initiative; it’s a calculated play to tap into the burgeoning demand for alternative funding solutions. Who's on Board? This venture isn't flying solo—it's got...

Continue Reading
Paysign's Q3 2024 Outcomes Show Remarkable Growth Trends

Updated Category News Views 205

Paysign's Strong Financial Performance in Q3 2024 Paysign, Inc. (NASDAQ: PAYS), a prominent entity in prepaid card programs and digital banking services, has reported impressive financial results for the third quarter of 2024. The company demonstrated robust revenue growth of 23.0%, translating to an increase of $2.86 million compared to the previous year. This growth...

Continue Reading